Activity based costing of medication to the individual in the public

Activity based costing of medication to the individual in
the public hospital setting.
Date:
May2015
Prepared by:
Dr Peter Cronin
Prepared for:
Activity Based Funding Conference 2015
Agenda
̶ Collaborators
̶ 1
Understand – Context, Question
̶ 2
Analyse – Analytics engine development
̶ 3
Communicate – Web based reporting
̶ Challenges
̶ Demo and Interim Results
̶ Opportunities
St Vincent’s Hospital, Sydney
• E health innovator
• First hospital in Aust to roll-out EMMS across inpatient wards incl ICU
• First hospital in Aust to connect to PCEHR and upload discharge summaries,
specialist letters, event notifications
• First hospital in NSW to implement wireless infusion pumps with dose error
reduction software
• First hospital in Aust to implement active RFID tracking of medical devices
• Developed, implemented and commercialised its in-house PAS and clinical
information systems
• 80:20 Rule …. The game is “communications and behaviour change”
• System integration … more than sum of parts …
• IT Department - nimble, flexible solutions. In-house, open source, vendor
Prospection
• Health analytics company – cloud based web platforms
• Medication utilisation– 200m script claims, geo-mapping
Medication vs Pharmacy costs
Direct Pharmacy costs = medication + salaries and
wages + goods and services + other
Source: Australia’s hospitals
2012-13 at a glance AIHW
Source: NHCDC COST WEIGHTS FOR ARDRG VERSION 6.0x, Round 17 (2012-13)
Defining Scope
In scope – Medication costs per DRG
• Medication costs only related to each inpatient episode of care including dispensed,
distributed and discharge medication using the average weighted inventory cost
Out of scope
• Outpatient Presentations
• Emergency Presentations and Admissions
• Inpatient medication documented on paper charts e.g. complex infusions (dobutamine,
levosimendan, heparin), insulins
• Maintenance fluids – e.g. sodium chloride 0.9% (distributed and costed by stores)
• Theatres – most intra-op medicines are recorded manually on “blue” paper chart
• Non-Medication Pharmacy costs
The Problem
• Activity Based Funding (ABF) - how can we allocate
medication costs to an individual patient?
Pharmacy
• Have the data but……
Inventory
(stock on hand)
Purchases
(info sent to Oracle / General
Ledger)
Distributed stock
(at SVHS inpatients approx. 60% of
drug costs)
Dispensed stock
Clinical Scenario – Blood and Marrow Transplant
Snapshot of MedChart® admins
Yellow = items kept on
this wards imprest
Green = individually
dispensed to the patient
Blue = chemotherapy externally manufactured
and costed to the patient
The challenges - data gathering
iPharmacy
• Medications
dispensed
(inpatient, leave,
discharge)
• Medications
distributed
(imprest, other)
• SKU level costing
• NSW HPPL
therapeutic
classifications
MedChart
• Administered
Medications
• Dose level
administration
• Phase 2: medication on
admission histories,
medication orders
(prescriptions),
discharge medications
PAS / HIE
• Patient info
• Admission info
(Episodes, AMO,
Specialty, Ward)
• DRG
(+ ICD 10 diagnoses)
Baxter
• Externally
compounded
medications
(Chemotherapy,
antibiotic infusors,
eyedrops)
• Costs
independently
charged
The Solution – interactive, visual
The Solution – drill down
Costing → Utilisation
The Opportunities
• Medication Costing → Other Costing
• Pathology
• Imaging etc
• Medication Costing → Medication Utilisation
•
•
•
•
Quality Use of Medicines Reporting
Treatment monitoring / outcomes
Specialties - Antimicrobial stewardship etc
Prediction models
Acknowledgements
̶
Prospection – Eric Chung, Ricky Chen, Meng Xie, Amelia Papamanos
̶
St Vincent’s Hospital – David Roffe, Kate Richardson, Skip Hodgson, Vinh Dinh
Bui, Melita Howes, Prof Ric Day.
̶
Centre for Health Informatics - Professor Enrico Coiera
̶
NSW Trade and Investment NSW Innovate Collaborative Solutions
̶
Ethics Approval: HREC : LNR/14/SVH/334
Prospection Pty Ltd
National Innovation Centre
Australian Technology Park
Suite 145, 4 Cornwallis Street
Eveleigh NSW 2015
Dr Peter Cronin
E [email protected]
P +61 (2) 9209 4035
M +61 413 803 072